Age

20–70

Sex

ALL

Healthy volunteers

Not accepted

Have participated in a prior imdusiran clinical trial,
Have discontinued NA therapy in that trial and remain off NA therapy,
Have completed less than 3 years of follow-up visits after NA discontinuation in the parent study.
Have the ability to review and provide signed informed consent which includes compliance with all protocol-specified visit schedules and requirements.

Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)